NEWS

CRO automates laboratories using clinical trial software

Australian clinical research organisation (CRO) Nucleus Network has selected Labpas CT, from Labpas, to fully automate its Phase 1 clinical trials. It is the sixth high-profile CRO to select the clinical trial software solution in the past year.

Andrew Giddy, CEO of Nucleus Network, claimed that Labpas CT has helped to raise the profile of the CRO in Australia, by increasing the efficiency of clinical trials and providing greater compliance to laboratory regulations.

The software streamlines clinical processes, such as recruitment, reporting and sample storage. It includes a bar code scanner to record collection times and dosage, and an electronic signature system to support FDA 21 CFR Part 11.

Nucleus Network has also volunteered to demonstrate the software on behalf of Labpas to Australian and Asian clients. Other CROs that have chosen the software include Cedra, Acclaim, and Advanced Biomedical Research.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers